Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Cellular glycosphingolipid (GSL) storage is known to promote cholesterol accumulation. Although physical interactions between GSLs and cholesterol are thought to cause intracellular cholesterol "trapping," it is not known whether cholesterol homeostatic mechanisms are also impaired under these conditions. ApoA-I-mediated cholesterol efflux via ABCA1 (ATP-binding cassette transporter A1) is a key regulator of cellular cholesterol balance. Here, we show that apoA-I-mediated cholesterol efflux was inhibited (by up to 53% over 8 h) when fibroblasts were treated with lactosylceramide or the glucocerebrosidase inhibitor conduritol B epoxide. Furthermore, apoA-I-mediated cholesterol efflux from fibroblasts derived from patients with genetic GSL storage diseases (Fabry disease, Sandhoff disease, and GM1 gangliosidosis) was impaired compared with control cells. Conversely, apoA-I-mediated cholesterol efflux from fibroblasts and cholesterol-loaded macrophage foam cells was dose-dependently stimulated (by up to 6-fold over 8 h) by the GSL synthesis inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP). Unexpectedly, a structurally unrelated GSL synthesis inhibitor, N-butyldeoxynojirimycin, was unable to stimulate apoA-I-mediated cholesterol efflux despite achieving similar GSL depletion. PDMP was found to up-regulate ABCA1 mRNA and protein expression, thereby identifying a contributing mechanism for the observed acceleration of cholesterol efflux to apoA-I. This study reveals a novel defect in cellular cholesterol homeostasis induced by GSL storage and identifies PDMP as a new agent for enhancing cholesterol efflux via the ABCA1/apoA-I pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIG. 1 Cellular GSL accumulation inhibits apoA-I-mediated cholesterol efflux. Control human fibroblasts ( A and B ) and SLSD fibroblasts ( C ) were grown in medium containing 0.2 𝛍 Ci/ml [ 3 H]cholesterol and 10% FCS for 72 h. After the initial 24 h, either 40 𝛍 M LacCer ( A ) or 50 𝛍 M CBE ( B ) was added as described under 'Experimental Procedures.' After equilibration (in the presence of LacCer or CBE where appropriate), cells were incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Aliquots of the media were removed at times up to 8 h, and the percent cholesterol efflux was calculated by dividing [ 3 H]cholesterol released to the medium by the total [ 3 H]cholesterol in the cells after equilibration ( t = 0 h). A : f , BSA; H18554 , BSA + LacCer; ● , apoA-I; E , apoA-I + LacCer. B and C : white bars , BSA; black bars , apoA-I. Con , control, Sand , Sandhoff disease. Values are the means ± S.E. from triplicate cultures of a single experiment, representative of three. *, p < 0.05; **, p < 0.01 (significantly different from apoA-I-dependent cholesterol efflux under control conditions).](https://figures.cochat.ai/paper-figures/2672331950fa465498b7e05547bf27fc/glycosphingolipid-accumulation-inhibits-cholesterol-efflux-via-the-abca1-figure-1.png)
![FIG. 2 Influence of LacCer on fibroblast phospholipid efflux to apoA-I and cholesterol efflux to apoA-I, PLVs, or MBCD. A , fibroblasts were grown as described in the legend to Fig. 1 and treated with 40 𝛍 M LacCer as indicated prior to analysis of [ 3 H]cholesterol and 3 H-phospholipid efflux to apoA-I as described under 'Experimental Procedures.' B , [ 3 H]cholesterol efflux to PLVs (200 𝛍 g/ml total phospholipid) or MBCD (250 𝛍 M) was also assessed. Data were derived after 8 h of efflux. Values represent the means ± S.E. from triplicate determinations. **, p < 0.01 (significantly different from cells treated with apoA-I alone). Con , control.](https://figures.cochat.ai/paper-figures/49a8c010899f4270b44b286de6c62892/glycosphingolipid-accumulation-inhibits-cholesterol-efflux-via-the-abca1-figure-2.png)

![FIG. 4 Expression of ABCA1 mRNA and acyl-CoA:cholesterol acyltransferase-accessible cholesterol in fibroblasts derived from normal subjects and patients with Fabry disease, Sandhoff disease, or GM1 gangliosidosis. A , fibroblasts were grown in DMEM and 10% FCS until confluent and washed three times with PBS; the RNA was extracted; and ABCA1 mRNA was quantified by real-time PCR. B , fibroblasts were labeled with [ 3 H]cholesterol as described in the legend to Fig. 1, and the cholesterol and cholesteryl ester fractions were isolated by TLC. Where indicated, control ( Con ) fibroblasts were also treated with 40 𝛍 M LacCer. The cellular cholesteryl ester content is expressed as a percentage of the total cholesterol. Values are relative to control cells and represent the means ± S.E. from triplicate determinations. **, p < 0.01; ***, p < 0.001 (significantly different from control cells). amt. , amount; Sand , Sandhoff disease.](https://figures.cochat.ai/paper-figures/b0be1ff8348040f48f0ef2ffb73d4803/glycosphingolipid-accumulation-inhibits-cholesterol-efflux-via-the-abca1-figure-4.png)


![FIG. 7 PDMP promotes apoA-I dependent-cholesterol and phospholipid efflux. Fibroblasts were grown in DMEM containing [ 3 H]cholesterol or [ 3 H]choline, 10% FCS, and 10 𝛍 M PDMP as indicated for 72 h. Cells were then washed, equilibrated (in the presence of PDMP where appropriate), and incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Aliquots of the media were removed at the indicated times, and the percent cholesterol and phospholipid efflux was calculated as described in the legend to Fig. 1. Values are the means ± S.E. from triplicate cultures, representative of seven experiments. ● , apoA-I; E , apoA-I + 10 𝛍 M PDMP; f , BSA; H18554 , BSA + 10 𝛍 M PDMP.](https://figures.cochat.ai/paper-figures/74ff3edac767422998e7cf7c9ccb59fc/glycosphingolipid-accumulation-inhibits-cholesterol-efflux-via-the-abca1-figure-7.png)
![FIG. 8 PDMP does not promote cholesterol efflux to PLVs or MBCD. Fibroblasts were grown in DMEM containing [ 3 H]cholesterol and 10% FCS or in the same medium supplemented with 10 𝛍 M PDMP ( cross-hatched ) for 72 h. Cells were then washed, equilibrated (in the presence of PDMP where appropriate), and incubated in DMEM containing 0.1% (w/v) BSA or in the same medium with the addition of 25 𝛍 g/ml apoA-I. Cholesterol efflux in the presence of PLVs ( A ) or MBCD ( B ) was also assessed. Aliquots of the media were removed after 8 h, and the percent cholesterol efflux was calculated as described in the legend to Fig. 1. Values are the means ± S.E. from triplicate cultures, representative of two experiments for each condition. Con , control.](https://figures.cochat.ai/paper-figures/85a01e301ddc4e4d86b2cec2025af735/glycosphingolipid-accumulation-inhibits-cholesterol-efflux-via-the-abca1-figure-8.png)

![FIG. 10 Effect of PDMP on Triton-soluble and Triton-insoluble cholesterol distribution. A , fibroblasts were grown in DMEM and 10% FCS with 0.2 mCi/ml [ 3 H]cholesterol ( 3H-Chol. ) or the same medium supplemented with 2.5, 10, or 40 𝛍 M PDMP for 72 h. Cells were then washed and equilibrated (in the presence of PDMP where appropriate) for 16 h. The cells were extracted into cold Triton X-100, and the detergent-insoluble ( Insol. ; ● ) and detergent-soluble ( Sol. ; E ) cholesterol levels were measured as described under 'Experimental Procedures.' B , the data are expressed as percent insoluble cholesterol. Values are the means ± S.E. from triplicate cultures. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (significantly different from control conditions).](https://figures.cochat.ai/paper-figures/7cf2028a1b8a4a46a9cd80227601e115/glycosphingolipid-accumulation-inhibits-cholesterol-efflux-via-the-abca1-figure-10.png)
![FIG. 11 Effect of NB-DNJ on fibroblast GSL levels, cholesterol solubility, and apoA-I-mediated cholesterol efflux. A , fibroblasts were grown in DMEM and 10% FCS with [ 3 H]cholesterol ( 3H-Chol. ) or [ 3 H]choline in the presence of 50 𝛍 M NB-DNJ ( cross-hatched ) as indicated for 72 h. Cells were then washed and equilibrated (in the presence of NB-DNJ where appropriate) for 16 h. The cells were assayed for cell-surface GM1 expression by CTxB binding, Triton X-100-insoluble cholesterol ( TX-100 ), or 8-h [ 3 H]cholesterol efflux in DMEM containing 0.1% (w/v) BSA (control ( Con )) or in the same medium with the addition of 25 𝛍 g/ml apoA-I as described under 'Experimental Procedures.' B , the effect of NB-DNJ on phospholipid efflux to apoA-I was analyzed. Values are the means ± S.E. from triplicate cultures, representative of two experiments, p < 0.05; ***, p < 0.01 (significantly different from parallel conditions without NB-DNJ treatment).](https://figures.cochat.ai/paper-figures/903afe61be864e7897e1ebed7b84e4b9/glycosphingolipid-accumulation-inhibits-cholesterol-efflux-via-the-abca1-figure-11.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This is consistent with previous observations that increasing mTORC1 signaling induced ROS production34, whereas inhibiting mTORC1 reduced ROS34–36.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts
Brown, D. A., & London, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000005200 · Cited by 2,344
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Simons, K., & Ikonen, E. (2000) · Science · doi:10.1126/science.290.5497.1721 · Cited by 1,275
Wang, N., Lan, D., Chen, W., Matsuura, F., & Tall, A. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403506101 · Cited by 1,061
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005
The ATP switch model for ABC transporters
Higgins, C. F., & Linton, K. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb836 · Cited by 748
The macrophage foam cell as a target for therapeutic intervention
Li, A. C., & Glass, C. K. (2002) · Nature Medicine · doi:10.1038/nm1102-1235 · Cited by 700
LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C., Kast, H. R., Mangelsdorf, D. J., & Tontonoz, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.507 · Cited by 683
Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport
Kobayashi, T., Beuchat, M.-H., Lindsay, M., Frias, S., Palmiter, R. D., Sakuraba, H., Parton, R. G., & Gruenberg, J. (1999) · Nature Cell Biology · doi:10.1038/10084 · Cited by 620
Oram, J. F., Lawn, R. M., Garvin, M. R., & Wade, D. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006738200 · Cited by 536
Regulation of the activity of the low density lipoprotein receptor in human fibroblasts
Brown, M. S., & Goldstein, J. L. (1975) · Cell · doi:10.1016/0092-8674(75)90182-8 · Cited by 482
ABCA1: the gatekeeper for eliminating excess tissue cholesterol
Oram, J. F., & Lawn, R. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31566-2 · Cited by 480
N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
Platt, F. M., Neises, G. R., Dwek, R. A., & Butters, T. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37202-2 · Cited by 455
Bortnick, A. E., Rothblat, G. H., Stoudt, G., Hoppe, K. L., Royer, L. J., McNeish, J., & Francone, O. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003407200 · Cited by 300
Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases
Puri, V., Watanabe, R., Dominguez, M., Sun, X., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (1999) · Nature Cell Biology · doi:10.1038/14084 · Cited by 289
Jamming the endosomal system: lipid rafts and lysosomal storage diseases
Simons, K. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01847-x · Cited by 243
Sphingolipids in Atherosclerosis and Vascular Biology
Chatterjee, S. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1523 · Cited by 242
Characterization of the Human ABCG1 Gene
Kennedy, M. A., Venkateswaran, A., Tarr, P. T., Xenarios, I., Kudoh, J., Shimizu, N., & Edwards, P. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105863200 · Cited by 217
Remaley, A. T., Schumacher, U. K., Stonik, J. A., Farsi, B. D., Nazih, H., & Brewer, H. B. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1813 · Cited by 204
Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport
Vruchte, D. T., Lloyd-Evans, E., Veldman, R. J., Neville, D. C. A., Dwek, R. A., Platt, F. M., van Blitterswijk, W. J., & Sillence, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311591200 · Cited by 195
Mendez, A. J., Lin, G., Wade, D. P., Lawn, R. M., & Oram, J. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007717200 · Cited by 191
Regulation of reverse cholesterol transport and clinical implications
Rader, D. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00615-5 · Cited by 191
Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I
Martinez, L. O., Agerholm-Larsen, B., Wang, N., Chen, W., & Tall, A. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307161200 · Cited by 185
Drobnik, W., Borsukova, H., Böttcher, A., Pfeiffer, A., Liebisch, G., Schütz, G. J., Schindler, H., & Schmitz, G. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.030404.x · Cited by 158
Zhang, W.-Y., Gaynor, P. M., & Kruth, H. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28641 · Cited by 147
Ledesma, M. D., Brügger, B., Bünning, C., Wieland, F. T., & Dotti, C. G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1761 · Cited by 141
Wong, J., Quinn, C. M., & Brown, A. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000148707.93054.7d · Cited by 139
Self-citationChoi, H. Y., Karten, B., Chan, T., Vance, J. E., Greer, W. L., Heidenreich, R. A., Garver, W. S., & Francis, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304553200 · Cited by 138
Lipid abnormalities in children with types A and B Niemann Pick disease
McGovern, M. M., Pohl-Worgall, T., Deckelbaum, R. J., Simpson, W. L., Mendelson, D., Desnick, R. J., Schuchman, E. H., & Wasserstein, M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.048 · Cited by 137
Glucosylceramide modulates membrane traffic along the endocytic pathway
Sillence, D. J., Puri, V., Marks, D. L., Butters, T. D., Dwek, R. A., Pagano, R. E., & Platt, F. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200232-jlr200 · Cited by 135
Yamauchi, Y., Hayashi, M., Abe-Dohmae, S., & Yokoyama, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306258200 · Cited by 134
Lusa, S., Blom, T. S., Eskelinen, E.-L., Kuismanen, E., Månsson, J.-E., Simons, K., & Ikonen, E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1893 · Cited by 132
Efflux of Cholesterol from Different Cellular Pools
Haynes, M. P., Phillips, M. C., & Rothblat, G. H. (2000) · Biochemistry · doi:10.1021/bi992125q · Cited by 126
Acid Sphingomyelinase-deficient Macrophages Have Defective Cholesterol Trafficking and Efflux
Leventhal, A. R., Chen, W., Tall, A. R., & Tabas, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106455200 · Cited by 122
Bhunia, A. K., Arai, T., Bulkley, G. B., & Chatterjee, S. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34349 · Cited by 113
Puri, V., Jefferson, J. R., Singh, R. D., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300304200 · Cited by 89
Structural Elucidation of the N- andO-Glycans of Human Apolipoprotein(a)
Garner, B., Merry, A. H., Royle, L., Harvey, D. J., Rudd, P. M., & Thillet, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102150200 · Cited by 89
Self-citationJohnson, W. J., Mahlberg, F. H., Chacko, G. K., Phillips, M. C., & Rothblat, G. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68190-6 · Cited by 89
Bhunia, A. K., Han, H., Snowden, A., & Chatterjee, S. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10660 · Cited by 88
Witting, S. R., Maiorano, J. N., & Davidson, W. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305193200 · Cited by 86
Blom, T. S., Koivusalo, M., Kuismanen, E., Kostiainen, R., Somerharju, P., & Ikonen, E. (2001) · Biochemistry · doi:10.1021/bi0156714 · Cited by 82
Glucosylceramide Synthase Inhibitor Inhibits the Action of Nerve Growth Factor in PC12 Cells
Mutoh, T., Tokuda, A., Inokuchi, J.-I., & Kuriyama, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26001 · Cited by 81
Glycosphingolipid Accumulation in the Aortic Wall Is Another Feature of Human Atherosclerosis
Mukhin, D. N., Chao, F.-F., & Kruth, H. S. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1607 · Cited by 81
Roosbeek, S., Peelman, F., Verhee, A., Labeur, C., Caster, H., Lensink, M. F., Cirulli, C., Grooten, J., Cochet, C., Vandekerckhove, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401821200 · Cited by 69
Ohvo, H., Olsio, C., & Slotte, J. P. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00126-4 · Cited by 66
Ito, J.-I., Nagayasu, Y., & Yokoyama, S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32031-9 · Cited by 66
Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
Garner, B., Priestman, D. A., Stocker, R., Harvey, D. J., Butters, T. D., & Platt, F. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30162-0 · Cited by 63
Self-citationYamauchi, Y., Chang, C. C. Y., Hayashi, M., Abe-Dohmae, S., Reid, P. C., Chang, T.-Y., & Yokoyama, S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400264-jlr200 · Cited by 62
Wing, D. R., Garner, B., Hunnam, V., Reinkensmeier, G., Andersson-Hall, U. K., Harvey, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5393 · Cited by 59
Self-citationBarbour, S., Edidin, M., Felding‐Habermann, B., Taylor‐Norton, J., Radin, N. S., & Fenderson, B. A. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500322 · Cited by 58
Garner, B., Dean, R. T., & Jessup, W. (1994) · Biochemical Journal · doi:10.1042/bj3010421 · Cited by 53
Self-citationOn the Cytoprotective Role of Ferritin in Macrophages and its Ability to Enhance Lysosomal Stability
Garner, B., Li, W., Roberg, K., & Brunk, U. T. (1997) · Free Radical Research · doi:10.3109/10715769709065788 · Cited by 52
Self-citationFielding, C. J., & Moser, K. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33916-4 · Cited by 52
Kockx, M., Rye, K.-A., Gaus, K., Quinn, C. M., Wright, J., Sloane, T., Sviridov, D., Fu, Y., Sullivan, D., Burnett, J. R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401177200 · Cited by 47
Self-citationQUINN, C. M., KÅGEDAL, K., TERMAN, A., STROIKIN, U., BRUNK, U. T., JESSUP, W., & GARNER, B. (2004) · Biochemical Journal · doi:10.1042/bj20031352 · Cited by 36
Self-citationLiu, S. M., Cogny, A., Kockx, M., Dean, R. T., Gaus, K., Jessup, W., & Kritharides, L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200464-jlr200 · Cited by 35
Self-citationGarner, B., Mellor, H. R., Butters, T. D., Dwek, R. A., & Platt, F. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6356 · Cited by 28
Self-citation[55] Inhibitors of cerebroside metabolism
Radin, N. S., & Vunnam, R. R. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)72057-3 · Cited by 27
Increase of gangliosides in atherosclerotic human aortas
Breckenridge, W. C., Halloran, J. L., Kovács, K., & Silver, M. D. (1975) · Lipids · doi:10.1007/bf02532490 · Cited by 24
Plasma lipoprotein responses to enzyme-replacement in Gaucher's disease
Cenarro, A., Pocovı́, M., Giraldo, P., García-Otín, A. L., & Ordovás, J. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00188-9 · Cited by 22
Research works printed but not linked: 1
- Radin, 1993, Adv. Lipid Res., 26, 183
Cited by
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
Kim, M., Wainwright, H. C., Locketz, M., Bekker, L., Walther, G. B., Dittrich, C., Visser, A., Wang, W., Hsu, F., Wiehart, U., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000079 · Cited by 489
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414
Lysosomal storage disorders – challenges, concepts and avenues for therapy: beyond rare diseases
Marques, A. R. A., & Saftig, P. (2019) · Journal of Cell Science · doi:10.1242/jcs.221739 · Cited by 224
Kim, W. S., Rahmanto, A. S., Kamili, A., Rye, K.-A., Guillemin, G. J., Gelissen, I. C., Jessup, W., Hill, A. F., & Garner, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607831200 · Cited by 191
Self-citation
Metadata
- Authors
- Glaros, E. N., Kim, W. S., Quinn, C. M., Wong, J., Gelissen, I., Jessup, W., & Garner, B.
- Affiliations
- UNSW Sydney (AU)
- Corresponding author
- Garner, Brett
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 280
- Issue
- 26
- Pages
- 24515-24523
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2134647594
- Cited by
- 75
- References
- 61
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 6 · 2013: 6 · 2012: 4
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5580 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Figshare (submittedVersion)
- Funders
- National Heart Foundation of Australia (222722)
- Medical Research Council
- National Health and Medical Research Council (350810)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- cholesterol efflux, ABCA1, apolipoprotein A-I, lactosylceramide, conduritol B epoxide, glucocerebrosidase, Fabry disease, Sandhoff disease, GM1 gangliosidosis, prescription drug monitoring programs, N-butyldeoxynojirimycin, cholesterol homeostasis, foam cells, fibroblasts
- MeSH terms
- Cell Line, Cell Membrane, Cholesterol, Chromatography, High Pressure Liquid, Dose-Response Relationship, Drug, Enzyme Inhibitors, Fibroblasts, Glycosphingolipids, Humans, Lactosylceramides, Lipoproteins, LDL, Monocytes, Morpholines, Phospholipids, RNA, Messenger, Time Factors, Blotting, Western, Antigens, CD, Up-Regulation, Apolipoprotein A-I, 1-Deoxynojirimycin, ATP-Binding Cassette Transporters, Biotinylation, Reverse Transcriptase Polymerase Chain Reaction, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.